
Can Bridge Bio's pulmonary fibrosis drug be transformed into cancer treatment?
Bridge Biotherapeutics’ clinical trial of its lead pipeline failed to meet statistical significance, prompting the company to revise its development strategy. The company has indicated plans to continue working on the pipeline through sub-analyses and …